The latest call
FetchingAstrana Health, Inc. reported on November 5, 2026. We are fetching the call transcript; its summary follows once the transcript is in.
$31.79+0.1%Nov 13 close
Figures through September 30, 2026, from the 10-Q filed November 6, 2026
Just reported
From Astrana Health, Inc.'s results release of November 5, 2026; its quarterly report has since been filed.
Actual
$1.02B
+7.1% y/y
+5.3% q/q
Guided
—
No guide given
Actual
$0.26
-35% q/q
Guided
—
No guide given
Actual
| Measure | 3 months toSep 30, 2026 | 3 months toSep 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $1B | $956M | +7.07% |
| Profit | $13M | $373K | +3,372.39% |
| Profit per share | $0.26 | $0.01 | +2,500.00% |
| Free Cash Flow | $12.4M | $7.4M | +68.02% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Astrana Health, Inc. reported on November 5, 2026. We are fetching the call transcript; its summary follows once the transcript is in.
“Our third quarter results demonstrate the growing impact of Astrana’s physician-centric, AI-native healthcare operating platform and our team’s continued focus on execution,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land before the open or after the close, so the window runs from the close before the report day to the close of the session after it — the reaction is inside it either way.
Entities The Company consolidates entities in which it has a controlling financial interest. The Company consolidates subsidiaries in which it holds, directly or indirectly, more than 50% of the voting rights, and variable interest entities (“VIEs”) in which the Company is the primary beneficiary. Non-controlling interests represent third party equity ownership interests in the Company’s consolidated entities (including certain VIEs). The amount of net income or loss attributable to non-controlling interests is disclosed in the Company’s consolidated statements of income.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Astrana Health, Inc.’s Item 2.02 8-K filed November 5, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
$39.9M
+108% y/y
+16% q/q
Guided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.